https://www.hcplive.com/view/covid-19-vaccine-safe-for-patients-with-hepatitis-c-virus-related-liver-disease
After receiving the COVID-19 vaccination, the antibody titers of patients with cirrhosis and hepatocellular carcinoma were significantly reduced compared to patients with chronic hepatitis C patients.
Create an account
or login to join the discussion